News

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...
Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Explore more
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...
Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...
A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
A study finds that adjunctive use of GLP-1 receptor agonists before and after undergoing bariatric surgery produces greater ...